WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff Relief: ... Chinese pharma firms may have escaped the immediate impact of U.S. President Donald Trump's newly announced 100% tariff on patented drugs, but longer-term threats from Wa...
(9/30/2025)

Novo vs. KBP: Fraud or Due Diligence Slipup? (... (10/17/2025)

First Drug Patent Term Extension Granted In Ch... (10/13/2025)

U.S. Senate Approves Revised China Biotech Com... (10/13/2025)

China's Innovative Drug Sector Secures Over CN... (10/13/2025)

Challenges and Opportunities in Oncology Drug ... (9/23/2025)

China's Edge over U.S. Biotech Was Never Scien... (9/23/2025)

China's Role in Global Drug Approvals Expands ... (9/22/2025)

PRC Consolidates Pharmaceutical Supply Chain D... (9/19/2025)

China Biopharma at Crossroads: A... (9/19/2025)

Gottlieb Cautions Blanket China Drug Licensing... (9/19/2025)

Obesity in China (The Lancet) (9/19/2025)

China's Biotechs Navigate the Demands of Inter... (9/19/2025)

Recent Executive Moves (10/17/2025) LEO Pharma's Anzupgo Cream NDA Accepted ... (10/17/2025) Gilead's Kite Strikes Up to $1.64B In Vi... (10/17/2025) RemeGen's Telitacicept Demonstrates Stro... (10/17/2025) Dianthus Secures Exclusive Global Rights... (10/17/2025) Roche Expands Oncology Pipeline Thru Glo... (10/17/2025) I-Mab to Rebrand as NovaBridge Bioscienc... (10/17/2025) NHC Holds High-Level Meetings with Abbot... (10/16/2025) China NMPA Cancels 80 Drug Registration ... (10/16/2025) Belite Bio Secures Priority Review from ... (10/16/2025) Kailera Launches with $600M Series B to... (10/16/2025) Xuanzhu Bio Soars on Hong Kong Debut Aft... (10/16/2025) Qilu Presents Promising Phase I Data for... (10/16/2025) Sino Biopharma's TQB2102 Receives Breakt... (10/15/2025) Pfizer CEO Calls for Greater U.S.–China... (10/15/2025) GSK's Shingrix Wins Chinese Approval for... (10/14/2025) Biokin and SystImmune Present Promising ... (10/14/2025) Multitude Reports Updated Safety and Dos... (10/14/2025)

China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M... China Drives Asia-Pacific Health Care Transformation Am...

I-Mab to Rebrand as NovaBridge Biosciences and Pursue H... Roche Expands Oncology Pipeline Thru Global Licensing D... Dianthus Secures Exclusive Global Rights to DNTH212 fro... Gilead's Kite Strikes Up to $1.64B In Vivo CAR-T Deal w... Xuanzhu Bio Soars on Hong Kong Debut After Highly Overs...

China NMPA Cancels 80 Drug Registration Certificates, I... China Introduces New Regulations to Govern Clinical Res... CDE Issues Guidance to Address Common Challenges in Ped... CDE Solicits Comments on Draft Guidelines for Bioequiva... CDE Seeks Input on Draft Technical Requirements for Sod...

China Expands Medical Insurance Coverage for Rare Disea... China Unveils New Rules for 11th Round of National Cent... China Launches Pilot Program for Real-World Comprehensi... China to Incorporate HPV Vaccines into National Immuniz... NHSA Seeks Feedback on Draft Implementation Rules for M...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

China Faces New Pressure as U.S. Eyes Middle East for D... FDA Issues Warning to Chengdu Biopharma Over cGMP Viola... China's Sharp API Price Cuts Jeopardize India's Self-Re... China Produces Dozens of Drugs Below Market Price – U.... India Moves to Set Minimum Import Prices to Protect Pha...

RemeGen's Telitacicept Demonstrates Strong Phase 3 Effi... LEO Pharma's Anzupgo Cream NDA Accepted in China Qilu Presents Promising Phase I Data for AR PROTAC Degr... Belite Bio Secures Priority Review from China's NMPA fo... Sino Biopharma's TQB2102 Receives Breakthru Therapeutic...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...